Skip to content
PeptideAgent

Compounding pharmacies in Hawaii

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

The Hawaii State Board of Pharmacy (Department of Commerce and Consumer Affairs) regulates compounding pharmacies in Hawaii. Compounded GLP-1 limited. How to check a pharmacy's license, plus verified listings.

Hawaii at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified compounding pharmacies serving Hawaii

No verified compounding pharmacies serving Hawaii are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Who regulates compounding pharmacies in Hawaii

The Hawaii State Board of Pharmacy, part of the Professional and Vocational Licensing Division of the Department of Commerce and Consumer Affairs, regulates pharmacies under HRS chapter 461. Hawaii has no separate state bulks list, so peptide eligibility follows the federal 503A framework (approved drug component, USP or NF monograph, or FDA 503A bulks list). HRS 461-14 makes it unlawful to operate a pharmacy in Hawaii without a Board permit, and HRS 461-15 requires any out-of-state pharmacy that ships, mails, or delivers prescription drugs into Hawaii to first obtain a Board permit, disclosing its principal officers, attesting to no drug law violations, keeping its home-state license in good standing, and employing a registered pharmacist in good standing. The Board's rules are Hawaii Administrative Rules chapter 16-95 (Pharmacists and Pharmacies). HAR 16-95-110(a)(17) makes failure to comply with the compounding requirements in USP chapters 795 (nonsterile preparations) and 797 (sterile preparations) a ground for discipline; the chapter has no separate compounding subchapter. [1] [3] [4] [6]

Compounded GLP-1 access in Hawaii

Because Hawaii rejects questionnaire-only prescribing, patients using national telehealth GLP-1 programs should expect a documented evaluation by a Hawaii-licensed physician, and any out-of-state pharmacy must hold a Hawaii out-of-state pharmacy permit. [2] [3] [9]

Research use only sellers in Hawaii

Only pharmacies permitted by the Hawaii Board of Pharmacy, including out-of-state pharmacies permitted under HRS 461-15, may dispense prescription drugs to Hawaii patients. "Research use only" peptides sold for human injection are unapproved new drugs under federal law and are not dispensed by a pharmacist. The Hawaii Food, Drug, and Cosmetic Act, HRS 328-17(a), separately bars any person from selling, delivering, holding for sale, or giving away a new drug unless an application for it has been approved under section 505 of the federal act (or, for a drug outside the federal act, filed with and not refused by the Hawaii director of health). [3] [5] [10]

Hawaii notes on specific peptides

  • Semaglutide: Available branded by prescription from a Hawaii-licensed physician, including by telehealth after a documented evaluation; HRS 453-1.3 rejects prescriptions based solely on an online questionnaire. Compounded semaglutide is limited to documented patient-specific needs since the 503A grace period ended April 22, 2025. [2] [9]

How to check a compounding pharmacy in Hawaii

  1. Search the Hawaii State Board of Pharmacy (Department of Commerce and Consumer Affairs) license lookup for the pharmacy by name. A pharmacy based elsewhere needs whatever license or registration Hawaii requires before it ships to you. [1] [3] [4] [6]
  2. Ask whether it operates as a 503A pharmacy or a 503B outsourcing facility, and confirm a 503B claim against FDA's outsourcing facility information (see the verification checklist).
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Hawaii. [3] [5] [10]

Common questions in Hawaii

What does a mainland pharmacy need to ship compounded peptides to Hawaii?

A Hawaii Board of Pharmacy permit for out-of-state pharmacies under HRS 461-15. The pharmacy must keep its home-state license in good standing, employ a registered pharmacist, and disclose its principal officers. Check the Professional and Vocational Licensing search before ordering. [1] [3]

Can a Hawaii pharmacy compound BPC-157?

No, not from bulk today. BPC-157 is not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk. State boards cannot authorize what federal law does not. Peptides still in FDA Category 2 cannot be compounded either. [7] [8]

All peptide legal questions for Hawaii

Sources

  1. [1]Hawaii State Board of Pharmacy, Professional and Vocational Licensing Division
  2. [2]Hawaii Revised Statutes section 453-1.3, Practice of telehealth
  3. [3]Hawaii Revised Statutes chapter 461, Pharmacists and pharmacy (including sections 461-14 and 461-15)
  4. [4]Hawaii Administrative Rules chapter 16-95, Pharmacists and Pharmacies (compilation, Board of Pharmacy)
  5. [5]Hawaii Revised Statutes section 328-17, New drugs, regulation of sale (Hawaii Legislature)
  6. [6]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  7. [7]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
  8. [8]FDA: Pharmacy Compounding Advisory CommitteeFDA
  9. [9]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  10. [10]21 U.S.C. 331, Prohibited acts